• Mashup Score: 1
    Online Event - 1 year(s) ago

    Already Registered? Click HereWhile therapeutic monoclonal antibodies (mAbs) have been on the market for over 25 years, it wasn’t until recently that the production of these essential biologics began to move away from traditional methods toward advanced bioproduction techniques like continuous processing. These next-gen bioprocessing technologies have proven to increase production speeds while…

    Tweet Tweets with this article
    • JOIN US LATER TODAY at 11 AM ET/ 8 AM PT!! @Cytiva and @chugai_cc will share their findings around the continuous processing of mAbs and more! There's still time to register now: https://t.co/QoqXg5HseN #monoclonalantibodies #mabs #bioprocessing https://t.co/lTy11XIcHa